genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Artificial Intelligence
From Model to Molecule: NVIDIA Doubles Down on AI Drug Discovery
AgBio
Let There Be Light: GreenLight Strives for Global RNA Equity to…
Coronavirus
Icosavax: Giving VLPs the VIP Treatment
CRISPR
Inscripta Eyes Broader Genome Editing Reach with $150M Series E
Drug Discovery
You Can See Manhattan from Your Lab: $3B “Cove” Campus Announced…
News
Aging
Mouse Study Suggests Maintaining Vit D Levels in Older People Could…
Genetics
Whole Exome Sequencing Reveals Novel Genetic Mitochondrial Disorder
Antibodies
Unique ADC Strategy Targets Leukemia
Alzheimers
Growth Rate of Disease-Causing Amyloid Fibers Now Measurable
Neurological Disorders
Lack of Self-Control Under Stress Does Not Cause Binge Eating, Brain…
Insights
All
Trends for 2020
Trends for 2021
Antisense
n-Lorem Makes Ultrarare Disease Treatment Personal
Bioprocessing
Getting the Most Out of Your Intensified Bioprocess
Antibodies
Whence the Facility Expansions?
Bioprocessing
CDMOs Embrace Innovative Tech to Create “Digital Threads”
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Renal Cancer
Renal Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Renal Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Renal Cancer
Researchers Discover Key Structures in Kidney Formation
Renal Cancer
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding Late-Stage Kidney Cancer Candidate
Renal Cancer
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Renal Cancer
Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy into the Clinic
Renal Cancer
Acceleron Halts Development of Cancer Candidate Dalantercept
Renal Cancer
New Mouse Model Developed for Investigating Kidney Cancer
Renal Cancer
Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers
Renal Cancer
Argos Says Lead Candidate Likely to Fail Phase III Trial
Renal Cancer
After RCC Trial Failure, Cerulean to Slash Headcount
Renal Cancer
AVEO Oncology Awards European Rights to Tivozanib for Up to $396.5M+
Renal Cancer
GSK, Idera Partner on Third-Gen Antisense Drugs for Renal Disease
Renal Cancer
AstraZeneca, Isis Pharma Expand Antisense Collaboration
Renal Cancer
FDA Rejects Aveo’s Tivozanib for RCC; Rips Phase III Results
Renal Cancer
Pfizer Drug Disappoints in Treatment-Naive RCC Study
1
2
3
Page 1 of 3
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
